Literature DB >> 12851612

Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon.

John F Beltrame1, Sananand B Limaye, Ronald D Wuttke, John D Horowitz.   

Abstract

BACKGROUND: The coronary slow flow phenomenon (CSFP) is an angiographic finding characterized by Thrombolysis in Myocardial Infarction (TIMI)-2 flow in the absence of significant large vessel coronary disease. Although clinical and pathological features have been previously described, the underlying pathophysiology has not been fully elucidated. This study investigates the persistence of the phenomenon on serial angiographic studies, coronary hemodynamic findings at rest and during provocative stimuli, and biochemical evidence of inducible myocardial ischemia.
METHODS: Twelve patients with CSFP underwent repeat angiography and coronary sinus canulation that allowed for the assessment of coronary blood flow, transmyocardial lactate, and oxygen extraction. Parameters were assessed at rest and during rapid atrial pacing, cold pressor stimulation, and acetylcholine infusion. Angiographic and coronary hemodynamic findings were compared with 47 patients who underwent angiography and 8 patients who were hemodynamic control subjects, respectively.
RESULTS: Persistent TIMI-2 flow was demonstrated with repeat angiography in only 4 of the patients. However, the corrected TIMI frame count remained delayed compared with that in control subjects. Furthermore, resting coronary sinus oxygen saturation was low compared with control subjects (23% +/- 4% vs 31% +/- 4%; P <.01), reflecting an increased basal coronary vasomotor tone. The coronary vasodilatory response to atrial pacing was similar to that in control subjects; however, several patients exhibited abnormal vasomotor responsiveness to cold pressor and acetylcholine stimuli. There was no evidence of nett myocardial lactate production with atrial pacing.
CONCLUSION: The CSFP is associated with a chronically elevated resting coronary microvascular tone, even when symptoms are relatively quiescent.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12851612     DOI: 10.1016/S0002-8703(03)00124-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  37 in total

Review 1.  Diagnosis of coronary microvascular dysfunction - Present status.

Authors:  S R Mittal
Journal:  Indian Heart J       Date:  2015-11-06

Review 2.  The coronary slow flow phenomenon: characteristics, mechanisms and implications.

Authors:  Xiao Wang; Shao-Ping Nie
Journal:  Cardiovasc Diagn Ther       Date:  2011-12

3.  Predictive Value of Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Patients with Coronary Slow Flow.

Authors:  Mustafa Çetin; Emrullah Kiziltunc; Özgül Uçar Elalmış; Zehra Güven Çetin; Muhammed Bora Demirçelik; Hülya Çiçekçioğlu; Alparslan Kurtul; Selçuk Özkan; Candan Mansuroğlu Avan; Ender Örnek; Feridun Vasfi Ulusoy
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

4.  Coronary microvascular dysfunction in patients with acute coronary syndrome and no obstructive coronary artery disease.

Authors:  Antonio De Vita; Laura Manfredonia; Priscilla Lamendola; Angelo Villano; Salvatore Emanuele Ravenna; Antonio Bisignani; Giampaolo Niccoli; Gaetano Antonio Lanza; Filippo Crea
Journal:  Clin Res Cardiol       Date:  2019-03-29       Impact factor: 5.460

5.  Evaluation of left atrial volume and function in patients with coronary slow flow phenomenon using real-time three-dimensional echocardiography.

Authors:  Yumeng Xing; Yongle Chen; Yu Liu; Dehong Kong; Yan Yan; Xianhong Shu; Cuizhen Pan
Journal:  Int J Cardiovasc Imaging       Date:  2019-07-25       Impact factor: 2.357

6.  Increased platelet activation in patients with slow coronary flow.

Authors:  Turgay Celik; U Cagdas Yuksel; Baris Bugan; Atila Iyisoy; Murat Celik; Sait Demirkol; Halil Yaman; Hurkan Kursaklioglu; Selim Kilic; Ersoy Isik
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

7.  Lack of association between the Glu298Asp polymorphism of endothelial nitric oxide synthase and slow coronary flow in the Turkish population.

Authors:  A O Caglayan; N Kalay; C Saatci; A Yalcýn; H Akalýn; M Dundar
Journal:  Can J Cardiol       Date:  2009-03       Impact factor: 5.223

8.  Acute phase proteins activation in subjects with coronary atherosclerosis and micro-vessel coronary circulation impairment.

Authors:  Natale Daniele Brunetti; Roberto Padalino; Luisa De Gennaro; Andrea Cuculo; Luigi Ziccardi; Pier Luigi Pellegrino; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2008-08-09       Impact factor: 2.300

Review 9.  Coronary microvascular dysfunction in the clinical setting: from mystery to reality.

Authors:  Joerg Herrmann; Juan Carlos Kaski; Amir Lerman
Journal:  Eur Heart J       Date:  2012-08-22       Impact factor: 29.983

10.  Thrombin activatable fibrinolysis inhibitor : its role in slow coronary flow.

Authors:  M N Yildirim; Y Selcoki; S Uysal; A B Nacar; B Demircelik; H I Aydin; B Eryonucu
Journal:  Herz       Date:  2013-09-27       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.